Literature DB >> 11889465

FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation.

Ilaria Meloni1, Maddalena Muscettola, Martine Raynaud, Ilaria Longo, Mirella Bruttini, Marie-Pierre Moizard, Marie Gomot, Jamel Chelly, Vincent des Portes, Jean-Pierre Fryns, Hans-Hilger Ropers, Barbara Magi, Cristina Bellan, Nila Volpi, Helger G Yntema, Sarah E Lewis, Jean E Schaffer, Alessandra Renieri.   

Abstract

X-linked mental retardation (XLMR) is an inherited condition that causes failure to develop cognitive abilities, owing to mutations in a gene on the X chromosome. The latest XLMR update lists up to 136 conditions leading to 'syndromic', or 'specific', mental retardation (MRXS) and 66 entries leading to 'nonspecific' mental retardation (MRX). For 9 of the 66 MRX entries, the causative gene has been identified. Our recent discovery of the contiguous gene deletion syndrome ATS-MR (previously known as Alport syndrome, mental retardation, midface hypoplasia, elliptocytosis, OMIM #300194), characterized by Alport syndrome (ATS) and mental retardation (MR), indicated Xq22.3 as a region containing one mental retardation gene. Comparing the extent of deletion between individuals with ATS-MR and individuals with ATS alone allowed us to define a critical region for mental retardation of approximately 380 kb, containing four genes. Here we report the identification of two point mutations, one missense and one splice-site change, in the gene FACL4 in two families with nonspecific mental retardation. Analysis of enzymatic activity in lymphoblastoid cell lines from affected individuals of both families revealed low levels compared with normal cells, indicating that both mutations are null mutations. All carrier females with either point mutations or genomic deletions in FACL4 showed a completely skewed X-inactivation, suggesting that the gene influences survival advantage. FACL4 is the first gene shown to be involved in nonspecific mental retardation and fatty-acid metabolism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11889465     DOI: 10.1038/ng857

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  37 in total

1.  Molecular modeling studies of Fatty acyl-CoA synthetase (FadD13) from Mycobacterium tuberculosis--a potential target for the development of antitubercular drugs.

Authors:  Nidhi Jatana; Sarvesh Jangid; Garima Khare; Anil K Tyagi; Narayanan Latha
Journal:  J Mol Model       Date:  2010-05-08       Impact factor: 1.810

2.  Mapping of a new locus for autosomal recessive non-syndromic mental retardation in the chromosomal region 19p13.12-p13.2: further genetic heterogeneity.

Authors:  L Basel-Vanagaite; A Alkelai; R Straussberg; N Magal; D Inbar; M Mahajna; M Shohat
Journal:  J Med Genet       Date:  2003-10       Impact factor: 6.318

3.  Transcriptome profile in Williams-Beuren syndrome lymphoblast cells reveals gene pathways implicated in glucose intolerance and visuospatial construction deficits.

Authors:  Anna Antonell; Mireia Vilardell; Luis A Pérez Jurado
Journal:  Hum Genet       Date:  2010-04-17       Impact factor: 4.132

Review 4.  X linked mental retardation: a clinical guide.

Authors:  F L Raymond
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

5.  Mutagenesis of rat acyl-CoA synthetase 4 indicates amino acids that contribute to fatty acid binding.

Authors:  Lori Stinnett; Tal M Lewin; Rosalind A Coleman
Journal:  Biochim Biophys Acta       Date:  2006-10-06

6.  Long-chain Acyl-CoA synthetase 4A regulates Smad activity and dorsoventral patterning in the zebrafish embryo.

Authors:  Rosa Linda Miyares; Cornelia Stein; Björn Renisch; Jennifer Lynn Anderson; Matthias Hammerschmidt; Steven Arthur Farber
Journal:  Dev Cell       Date:  2013-12-12       Impact factor: 12.270

7.  Differential effects of polyunsaturated fatty acids on membrane capacitance and exocytosis in rat pheochromocytoma-12 cells.

Authors:  Wee-Liat Ong; Bin Jiang; Ning Tang; Su-Fung Ling; Jin-Fei Yeo; Shunhui Wei; Akhlaq A Farooqui; Wei-Yi Ong
Journal:  Neurochem Res       Date:  2006-01       Impact factor: 3.996

8.  Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4.

Authors:  Hiren R Modi; Mireille Basselin; Stanley I Rapoport
Journal:  Bipolar Disord       Date:  2014-07-08       Impact factor: 6.744

Review 9.  Acyl-CoA metabolism and partitioning.

Authors:  Trisha J Grevengoed; Eric L Klett; Rosalind A Coleman
Journal:  Annu Rev Nutr       Date:  2014-04-10       Impact factor: 11.848

10.  Array-CGH in unclear syndromic nephropathies identifies a microdeletion in Xq22.3-q23.

Authors:  Alexander Hoischen; Christina Landwehr; Sarah Kabisch; Xiao-Qi Ding; Detlef Trost; Gerhard Stropahl; Marianne Wigger; Bernhard Radlwimmer; Ruthild G Weber; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2009-05-15       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.